An IGF-1R targeted peptide drug conjugate for targeted treatment of atypical teratoid/rhabdoid tumors Grant uri icon

Overview

date/time interval

  • September 19, 2023 - August 31, 2025

sponsor award ID

  • 1 R41 CA285172-01

Affiliation